Trials / Completed
CompletedNCT04743414
Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects
A Phase 1 Open-Label Study to Assess the Effect of a Strong CYP3A4 Inhibitor, Itraconazole, on the Single Dose Pharmacokinetic Profile of CTP-543 in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Concert Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 1 open-label study of the effect of itraconazole on the pharmacokinetics of CTP-543 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CTP-543 | Itraconazole in solution dosage form |
Timeline
- Start date
- 2021-03-02
- Primary completion
- 2021-03-27
- Completion
- 2021-04-05
- First posted
- 2021-02-08
- Last updated
- 2021-04-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04743414. Inclusion in this directory is not an endorsement.